Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc.

Johnson & Johnson (NYSE: JNJ) announced today that Ethicon, Inc., has completed the acquisition of Auris Health, Inc. for approximately $3.4 billion in cash. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. With Auris Health's robotic platform technology, currently used in diagnostic and therapeutic procedures in the lung, Johnson & Johnson will advance its commitment to combatting lung cancer and expand…

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=238460


Source: webwire
Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc.



Leave a Reply